Eton Pharmaceuticals, Inc. (ETON)

3.1200 -0.0900 (-2.80%) At close: 04:00PM EDT

Eton Pharmaceuticals, Inc.

21925 W. Field Parkway
Suite 235
Deer Park, IL 60010-7278
United States
847 787 7361
https://www.etonpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 30

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Sean E. Brynjelsen	President, CEO & Director	868.13k	N/A	1972
Mr. James R. Gruber CPA	CFO, Treasurer & Secretary	457.58k	N/A	1972
Mr. David C. Krempa	Chief Business Officer	N/A	N/A	1989
Ms. Ingrid Hoos	Senior Vice President of Regulatory Affairs	N/A	N/A	N/A
Mr. Kevin Guthrie	Executive VP of Commercial Operations	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Corporate governance

Eton Pharmaceuticals, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.